Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Clinical Study Evaluating the Efficacy and Safety of NWRD09 in Patients With Persistent Cervical HPV16 Infection

NCT07710703 is registered in ClinicalTrials.gov with Newish Biotech (Wuxi) Co., Ltd. as lead sponsor.

NCT NCT07710703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07710703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Clinical Study Evaluating the Efficacy and Safety of NWRD09 in Patients With Persistent Cervical HPV16 Infection
Lead sponsor
Newish Biotech (Wuxi) Co., Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
February 10, 2026
Completion date
May 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

persistent cervical hpv16 infection